These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34074128)

  • 1. Three-Dimensional Idiopathic Pulmonary Fibrosis Model Using a Layer-by-Layer Cell Coating Technique.
    Kuno H; Akagi T; Fukui E; Yamato H; Akashi M; Shintani Y
    Tissue Eng Part C Methods; 2021 Jun; 27(6):378-390. PubMed ID: 34074128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Human Three-Dimensional Lung Model Using Layer-by-Layer Method.
    Akamatsu Y; Akagi T; Sumitomo T; Takahara Y; Akiyama S; Kawabata S; Akashi M
    Tissue Eng Part C Methods; 2023 Mar; 29(3):95-102. PubMed ID: 36721369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
    Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
    Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening.
    Vazquez-Armendariz AI; Barroso MM; El Agha E; Herold S
    Cells; 2022 May; 11(9):. PubMed ID: 35563831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
    Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
    Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Lung Tissue Implanted on the Chick Chorioallantoic Membrane as a Novel
    Perreault A; Harper K; Lebel M; Charbonneau M; Adam D; Brochiero E; Cantin AM; Leduc M; Gagnon L; Dubois CM
    Am J Respir Cell Mol Biol; 2022 Aug; 67(2):164-172. PubMed ID: 35612953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study.
    Milara J; Ballester B; Morell A; Ortiz JL; Escrivá J; Fernández E; Perez-Vizcaino F; Cogolludo A; Pastor E; Artigues E; Morcillo E; Cortijo J
    Thorax; 2018 Jun; 73(6):519-529. PubMed ID: 29440315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.
    Marinković A; Liu F; Tschumperlin DJ
    Am J Respir Cell Mol Biol; 2013 Apr; 48(4):422-30. PubMed ID: 23258227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis.
    Jaffar J; Glaspole I; Symons K; Westall G
    Biomed Pharmacother; 2021 Jun; 138():111471. PubMed ID: 33730605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast paracrine TNF-α signaling elevates integrin A5 expression in idiopathic pulmonary fibrosis (IPF).
    Epstein Shochet G; Brook E; Israeli-Shani L; Edelstein E; Shitrit D
    Respir Res; 2017 Jun; 18(1):122. PubMed ID: 28629363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.
    Park JK; Coffey NJ; Bodine SP; Zawatsky CN; Jay L; Gahl WA; Kunos G; Gochuico BR; Malicdan MCV; Cinar R
    Am J Respir Cell Mol Biol; 2020 Feb; 62(2):178-190. PubMed ID: 31419911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis.
    Wang Y; Yella JK; Ghandikota S; Cherukuri TC; Ediga HH; Madala SK; Jegga AG
    Ther Adv Respir Dis; 2020; 14():1753466620971143. PubMed ID: 33167785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-derived extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA-29b-3p in idiopathic pulmonary fibrosis.
    Wan X; Chen S; Fang Y; Zuo W; Cui J; Xie S
    J Cell Physiol; 2020 Nov; 235(11):8613-8625. PubMed ID: 32557673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
    Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
    Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin plays a critical role in the cell cycle in lung fibroblasts.
    Yoshihara T; Nanri Y; Nunomura S; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Mawatari M; Izuhara K
    Respir Res; 2020 Jan; 21(1):38. PubMed ID: 32000779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
    Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
    Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor paracrine upregulation in idiopathic pulmonary fibrosis fibroblasts is blocked by nintedanib.
    Epstein Shochet G; Brook E; Eyal O; Edelstein E; Shitrit D
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1025-L1034. PubMed ID: 30810067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis.
    Geng J; Huang X; Li Y; Xu X; Li S; Jiang D; Liang J; Jiang D; Wang C; Dai H
    Respir Res; 2015 Oct; 16():124. PubMed ID: 26453058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.